A prospective year-long follow-up of lurasidone use in clinical practice: factors predicting treatment persistence.
Journal Information
Full Title: Ther Adv Psychopharmacol
Abbreviation: Ther Adv Psychopharmacol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Pharmacology & Pharmacy
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflict of interest statement: This research was funded by an unrestricted grant from Sunovion. DT has received speaker honoraria from Janssen, Servier, Otsuka, Lundbeck and Eli Lilly."
"Funding: This research was funded by an unrestricted grant from Sunovion. The sponsor had no role in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication. The sponsor was shown a final draft of the report before submission to allow for the alerting of factual errors regarding their product. No changes were suggested. IJO and SM declare no competing interests."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025